FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157267761> ?p ?o ?g. }

• W3157267761 abstract "Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect that largely remains an unresolved clinical issue, leading to long-term morbidity. This meta-analysis aimed to evaluate the efficacy and safety of Ganglioside-monosialic acid (GM1) in preventing CIPN.Systematic literature searches of PubMed, Web of Science, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were performed to identify randomized controlled trials and cohort studies that evaluated the efficacy of GM1 for preventing CIPN. Conventional meta-analysis with a random-effects model and trial sequential analysis (TSA) were performed.A total of five studies involving 868 participants were included. The results showed that GM1 did not reduce the overall incidence of grade ≥ 2 CIPN when the common terminology criteria for adverse events (CTCAE) was used (OR 0.34, 95% CI 0.34-1.11). Subgroup analyses showed that GM1 could not reduce the risk of CTCAE grade ≥ 2 CIPN (OR 0.63, 95% CI 0.35-1.13) and neurotoxicity criteria of Debiopharm (DEB-NTC) grade ≥ 2 CIPN (OR 0.25, 95% CI 0.01-7.10) in oxaliplatin-treated patients, despite that GM1 was associated with a reduced risk of CTCAE grade ≥ 2 CIPN in the taxane subgroup of one study (OR 0.003, 95% CI 0.00-0.05). These results were confirmed by the sub-analysis of randomized controlled trials (RCTs). In TSA, the z-curve for the taxane subgroup crossed the upper trial sequential monitoring boundary (TSMB) but do not reach the required information size (RIS). The z-curves for the oxaliplatin subgroup remained in the nonsignificant area and did not reach the RIS. Further, GM1 did not influence the rate of response to chemotherapy and CTCAE grade ≥ 2 adverse events such as fatigue, nausea, diarrhea, and rash.GM1 seemed to be well-tolerated and did not influence the anti-cancer effects of chemotherapeutic agents. Although the data did not confirm the effectiveness of GM1 in preventing oxaliplatin-induced peripheral neuropathy, GM1 might be able to prevent taxane-induced peripheral neuropathy. More studies are required in different ethnic populations receiving taxane-based chemotherapy to confirm these findings." @default.
• W3157267761 created "2021-05-10" @default.
• W3157267761 creator A5006685364 @default.
• W3157267761 creator A5013890597 @default.
• W3157267761 creator A5025402885 @default.
• W3157267761 creator A5032058665 @default.
• W3157267761 creator A5056490700 @default.
• W3157267761 creator A5067066645 @default.
• W3157267761 creator A5083192880 @default.
• W3157267761 date "2021-11-02" @default.
• W3157267761 modified "2023-09-26" @default.
• W3157267761 title "Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis" @default.
• W3157267761 cites W1550227150 @default.
• W3157267761 cites W193125687 @default.
• W3157267761 cites W1978269641 @default.
• W3157267761 cites W1979423827 @default.
• W3157267761 cites W1996167718 @default.
• W3157267761 cites W2002553781 @default.
• W3157267761 cites W2005501262 @default.
• W3157267761 cites W2035512416 @default.
• W3157267761 cites W2049716446 @default.
• W3157267761 cites W2052340062 @default.
• W3157267761 cites W2095549072 @default.
• W3157267761 cites W2099210388 @default.
• W3157267761 cites W2107263116 @default.
• W3157267761 cites W2114458368 @default.
• W3157267761 cites W2123945981 @default.
• W3157267761 cites W2129307536 @default.
• W3157267761 cites W2139248078 @default.
• W3157267761 cites W2157877349 @default.
• W3157267761 cites W2335127767 @default.
• W3157267761 cites W2403813547 @default.
• W3157267761 cites W2508351939 @default.
• W3157267761 cites W2531269403 @default.
• W3157267761 cites W2588681363 @default.
• W3157267761 cites W2673256467 @default.
• W3157267761 cites W2795264498 @default.
• W3157267761 cites W2909887958 @default.
• W3157267761 cites W2946289592 @default.
• W3157267761 cites W2946625797 @default.
• W3157267761 cites W2962968022 @default.
• W3157267761 cites W2970684805 @default.
• W3157267761 cites W2994209498 @default.
• W3157267761 cites W2999195703 @default.
• W3157267761 cites W3003365674 @default.
• W3157267761 cites W3013790113 @default.
• W3157267761 cites W3021119615 @default.
• W3157267761 cites W3027571795 @default.
• W3157267761 cites W3037666169 @default.
• W3157267761 cites W3042992354 @default.
• W3157267761 cites W3043680095 @default.
• W3157267761 doi "https://doi.org/10.1186/s12885-021-08884-4" @default.
• W3157267761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8564974" @default.
• W3157267761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34727879" @default.
• W3157267761 hasPublicationYear "2021" @default.
• W3157267761 type Work @default.
• W3157267761 sameAs 3157267761 @default.
• W3157267761 citedByCount "1" @default.
• W3157267761 countsByYear W31572677612022 @default.
• W3157267761 crossrefType "journal-article" @default.
• W3157267761 hasAuthorship W3157267761A5006685364 @default.
• W3157267761 hasAuthorship W3157267761A5013890597 @default.
• W3157267761 hasAuthorship W3157267761A5025402885 @default.
• W3157267761 hasAuthorship W3157267761A5032058665 @default.
• W3157267761 hasAuthorship W3157267761A5056490700 @default.
• W3157267761 hasAuthorship W3157267761A5067066645 @default.
• W3157267761 hasAuthorship W3157267761A5083192880 @default.
• W3157267761 hasBestOaLocation W31572677611 @default.
• W3157267761 hasConcept C126322002 @default.
• W3157267761 hasConcept C134018914 @default.
• W3157267761 hasConcept C143998085 @default.
• W3157267761 hasConcept C168563851 @default.
• W3157267761 hasConcept C187960798 @default.
• W3157267761 hasConcept C197934379 @default.
• W3157267761 hasConcept C2776478404 @default.
• W3157267761 hasConcept C2777793932 @default.
• W3157267761 hasConcept C2779289229 @default.
• W3157267761 hasConcept C2779901536 @default.
• W3157267761 hasConcept C555293320 @default.
• W3157267761 hasConcept C71924100 @default.
• W3157267761 hasConcept C95190672 @default.
• W3157267761 hasConceptScore W3157267761C126322002 @default.
• W3157267761 hasConceptScore W3157267761C134018914 @default.
• W3157267761 hasConceptScore W3157267761C143998085 @default.
• W3157267761 hasConceptScore W3157267761C168563851 @default.
• W3157267761 hasConceptScore W3157267761C187960798 @default.
• W3157267761 hasConceptScore W3157267761C197934379 @default.
• W3157267761 hasConceptScore W3157267761C2776478404 @default.
• W3157267761 hasConceptScore W3157267761C2777793932 @default.
• W3157267761 hasConceptScore W3157267761C2779289229 @default.
• W3157267761 hasConceptScore W3157267761C2779901536 @default.
• W3157267761 hasConceptScore W3157267761C555293320 @default.
• W3157267761 hasConceptScore W3157267761C71924100 @default.
• W3157267761 hasConceptScore W3157267761C95190672 @default.
• W3157267761 hasIssue "1" @default.
• W3157267761 hasLocation W31572677611 @default.
• W3157267761 hasLocation W31572677612 @default.
• W3157267761 hasLocation W31572677613 @default.
• W3157267761 hasLocation W31572677614 @default.
• W3157267761 hasLocation W31572677615 @default.

• next